Gts Securities LLC Drug Manufacturers

Gts Securities LLC

Stock	Market Cap.	Holding Value (Reported)	# of Shares.	Last Trade
PFE Pfizer Inc	$139B	$23.1 Million 0.05% of portfolio	798,097	Q3 2024 Reduced 19.88%
LLY Eli Lilly & CO	$709B	$14.7 Million 0.03% of portfolio	16,559	Q3 2024 Added 12.89%
BMY Bristol Myers Squibb CO	$120B	$8.94 Million 0.02% of portfolio	172,757	Q3 2024 Reduced 41.65%
GILD Gilead Sciences, Inc.	$111B	$8.1 Million 0.02% of portfolio	96,684	Q3 2024 Added 20.33%
SNY Sanofi	$120B	$5.99 Million 0.01% of portfolio	103,909	Q3 2024 Added 312.89%
ABBV Abb Vie Inc.	$292B	$4.61 Million 0.01% of portfolio	23,322	Q3 2024 Added 154.08%
AMGN Amgen Inc	$152B	$3.95 Million 0.01% of portfolio	12,258	Q3 2024 Added 204.85%
GRFS Grifols Sa	$6.43B	$2.73 Million 0.01% of portfolio	307,782	Q3 2024 New
BIIB Biogen Inc.	$23B	$2.58 Million 0.01% of portfolio	13,294	Q3 2024 Reduced 4.48%
JNJ Johnson & Johnson	$403B	$2.35 Million 0.01% of portfolio	14,509	Q3 2024 Reduced 69.42%
MRK Merck & Co., Inc.	$244B	$1.5 Million 0.0% of portfolio	13,214	Q3 2024 Reduced 53.13%
NVS Novartis Ag	$222B	$942,000 0.0% of portfolio	8,190	Q3 2024 New
AZN Astrazeneca PLC	$196B	$457,000 0.0% of portfolio	5,876	Q3 2024 Reduced 41.33%

Get notified when there are updates to the investment portfolio of Gts Securities LLC, based on Form 13F filings with the SEC.

Stay updated on Gts Securities LLC with notifications on news.